ECL
57
3
BIIB
38
2
BXP
49
2
VLO
33
3
UA
48
9
AA
47
4
ETR
66
3
RSG
62
2
HAS
37
4
MSI
63
2
RF
54
3
PEP
47
2
EXR
57
7
KSS
42
4
AKAM
54
3
GLW
48
2
INTC
44
5
THC
67
2
MDLZ
38
2
UPS
28
3
ECL
57
3
BIIB
38
2
BXP
49
2
VLO
33
3
UA
48
9
AA
47
4
ETR
66
3
RSG
62
2
HAS
37
4
MSI
63
2
RF
54
3
PEP
47
2
EXR
57
7
KSS
42
4
AKAM
54
3
GLW
48
2
INTC
44
5
THC
67
2
MDLZ
38
2
UPS
28
3
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
47

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
64.10
Seasonality Move:
14.04%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.3% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $63.13. The Score for BIB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.3% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
47
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
40.54

Prediction Charts

Market Cap:
0
Price in USD:
63.13
Volume:
4.58K
Beta:
1.84

Technical Analysis

SMA50:
63.97
SMA100:
63.55
SMA200:
59.80
52-Wk Change:
38.08%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 63.13 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-17 65.81 65.15 65.81 65.08
Oct-18 64.65 65.21 65.50 64.38
Oct-21 64.93 63.32 64.99 62.94
Oct-22 62.48 63.48 63.50 62.10
Oct-23 62.72 61.94 62.72 61.29
Oct-24 62.00 61.73 62.77 61.52
Oct-25 62.17 61.85 62.89 61.72
Oct-28 62.94 63.13 63.70 62.72
Oct-29 63.09 62.71 63.23 62.29
Oct-30 62.82 62.10 63.01 61.68
Oct-31 61.02 60.16 61.05 60.16
Nov-1 60.38 61.67 61.67 60.38
Nov-4 62.22 61.89 62.46 61.15
Nov-5 61.16 63.13 63.13 60.95

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.